Australia & Dane Stevens
7 shared events · Importance 4 · Last updated Sep 23, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Business
Australia: Australia is the recipient country for Optimi Health's psilocybin capsules, providing a regulated market for the treatment of treatment-resistant depression and setting a model for psychedelic medicine use.
Dane Stevens: Dane Stevens, CEO and Co-Founder of Optimi Health, expressed pride in the company's commercial supply of psilocybin and highlighted Australia's role as a model for regulated psychedelic medicine.
Jun 29, 2026 · 12 articles
Business
Australia: Australia is currently a commercial market where Optimi Health's 5mg psilocybin capsules are prescribed to patients for treatment-resistant depression, demonstrating an existing successful market for the company's products.
Dane Stevens: Dane Stevens, CEO and Co-Founder of Optimi Health, highlighted the significance of the company's first shipment to the United Kingdom and its unique position as a vertically integrated GMP supplier.
Jun 02, 2026 · 25 articles
Tech
Australia: Australia is a market where Optimi Health Corp.'s 5mg psilocybin formulation is already commercially prescribed for treatment-resistant depression under the country's Authorized Prescriber Scheme.
Dane Stevens: Dane Stevens, CEO and Co-Founder of Optimi Health Corp., announced the launch of the new microdose psilocybin products, highlighting their consistent dosage for controlled research.
Jun 16, 2026 · 11 articles
Business
Australia: Optimi's products are prescribed to patients in Australia under the Authorized Prescriber Scheme, representing a current market for its psychedelic therapies.
Dane Stevens: As CEO and co-founder, he announced and commented on the appointment, highlighting its importance for the company's clinical trials.
Sep 22, 2026 · 7 articles
Tech
Australia: Australia is mentioned as a market where Optimi's products are prescribed under the Authorized Prescriber Scheme, indicating existing international reach. It is not directly involved in the trial.
Dane Stevens: As CEO and Co-Founder of Optimi Health, Dane Stevens announced the trial and emphasized its strategic importance. His leadership is tied to the company's clinical development strategy.
Sep 10, 2026 · 15 articles
Business
Australia: Australia is cited as a market where Optimi Health products are prescribed to patients under the Authorized Prescriber Scheme, illustrating the company's international reach.
Dane Stevens: Dane Stevens is identified as CEO of Optimi Health and the investor contact for the company; he is not reported to have a specific speaking role at the conference.
Sep 08, 2026 · 6 articles
Business
Dane Stevens: Dane Stevens, CEO of Optimi Health, highlighted the significance of the production and export runs in expanding access to psychedelic treatments in Australia.
Jan 26, 2026 · 6 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Australia and Dane Stevens interact across events, view sentiment trends, and discover connected entities.
Open Dashboard